Lisata Therapeutics (LSTA) Equity Average (2016 - 2025)
Historic Equity Average for Lisata Therapeutics (LSTA) over the last 12 years, with Q3 2025 value amounting to $19.2 million.
- Lisata Therapeutics' Equity Average fell 4661.87% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year decrease of 4661.87%. This contributed to the annual value of $38.9 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, Lisata Therapeutics' Equity Average stood at $19.2 million, which was down 4661.87% from $23.2 million recorded in Q2 2025.
- Over the past 5 years, Lisata Therapeutics' Equity Average peaked at $59.5 million during Q2 2023, and registered a low of $19.2 million during Q3 2025.
- Moreover, its 3-year median value for Equity Average was $40.6 million (2024), whereas its average is $39.3 million.
- Its Equity Average has fluctuated over the past 5 years, first surged by 573.05% in 2024, then crashed by 4661.87% in 2025.
- Lisata Therapeutics' Equity Average (Quarter) stood at $50.6 million in 2023, then tumbled by 37.43% to $31.6 million in 2024, then tumbled by 39.3% to $19.2 million in 2025.
- Its last three reported values are $19.2 million in Q3 2025, $23.2 million for Q2 2025, and $27.5 million during Q1 2025.